Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorDoğan, Berna
dc.contributor.authorErol, Muhammet Kazım
dc.contributor.authorToslak, Devrim
dc.contributor.authorÇoban, Deniz Turgut
dc.contributor.authorBulut, Mehmet
dc.contributor.authorCengiz, Ayşe
dc.contributor.authorSarı, Esin Söğütlü
dc.date.accessioned2019-11-18T07:36:50Z
dc.date.available2019-11-18T07:36:50Z
dc.date.issued2015en_US
dc.identifier.issn1178-203X
dc.identifier.urihttps://doi.org/10.2147/TCRM.S79232
dc.identifier.urihttps://hdl.handle.net/20.500.12462/9822
dc.descriptionSarı, Esin Söğütlü (Balikesir Author)en_US
dc.description.abstractBone marrow-derived multiple myeloma is a type of plasma cell tumor that may be associated with ocular complications. A 52-year-old male patient was admitted to our eye clinic with the complaint of sudden visual loss and a visual acuity of 20/50 in the right eye and 20/800 in the left eye. Fundus examination revealed common flame-shaped hemorrhages, venous dilatation and tortuosity, Roth spots, serous macular detachment, and yellow macular deposits in both eyes. Evaluation with fundus fluorescein angiography, fundus autofluorescence, and spectral-domain optical coherence tomography resulted in suspicion of hyperviscosity retinopathy and referral to the hematology clinic. After hematology consultation confirmed a diagnosis of multiple myeloma, chemotherapy and plasmapheresis were initiated. Four months after presentation, best-corrected visual acuity was 20/20 in both eyes and improvement in hyperviscosity retinopathy, serous macular detachment, and yellow macular deposits was observed.en_US
dc.language.isoengen_US
dc.publisherDove Medical Press Ltden_US
dc.relation.isversionof10.2147/TCRM.S79232en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSerous Macular Detachmenten_US
dc.subjectYellow Macular Depositen_US
dc.subjectProminent Middle Limiting Membraneen_US
dc.subjectMultiple Myelomaen_US
dc.titleSerous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myelomaen_US
dc.typearticleen_US
dc.relation.journalTherapeutics and Clinical Risk Managementen_US
dc.contributor.departmentTıp Fakültesien_US
dc.identifier.volume11en_US
dc.identifier.startpage683en_US
dc.identifier.endpage689en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster